Palantir a high-risk investment with ’a one-of-a-kind growth and margin model’
NEW YORK - Gelteq Limited (NASDAQ: GELS), an Australian company specializing in gel-based delivery solutions for various products, has entered into an exclusive logistics and distribution agreement with Healthy Extracts Inc. (OTCQB: HYEX). This partnership designates Healthy Extracts as the exclusive North American partner for storage, shipping, and fulfillment of Gelteq’s product lines. With a current market capitalization of $16.04 million, Gelteq faces significant challenges, as indicated by several key metrics available on InvestingPro.
The collaboration, announced today, aims to leverage Healthy Extracts’ infrastructure to enhance Gelteq’s distribution capabilities across the United States and Canada. Nathan Givoni, CEO of Gelteq, expressed confidence that this partnership will expedite the delivery of their products and improve customer reach. "This fulfillment partnership with Healthy Extracts creates a powerful springboard for our North American expansion," Givoni stated. The company’s expansion efforts come amid challenging financial conditions, with revenue declining by 58.21% and an EBITDA of -$1.05 million in the last twelve months. InvestingPro analysis suggests the stock is currently overvalued based on its Fair Value assessment.
Healthy Extracts will manage all aspects of logistics, including product receiving, warehousing, inventory, and order fulfillment from its Henderson, Nevada facility. The company’s President, Duke Pitts, anticipates that this will lead to increased margin efficiencies and revenue growth opportunities for both entities.
The agreement includes the integration of operational systems to improve inventory management and logistics efficiency. Initial products under this agreement are expected to reach the market by Q3 2025. Both companies anticipate that this vertical alignment will support their growth strategies, innovation efforts, and entry into new consumer markets.
Gelteq, headquartered in Melbourne, develops white label gel-based delivery solutions for a diverse range of sectors including pharmaceuticals, nutraceuticals, pet care, and sports nutrition. The company’s proprietary formulations are designed to address common issues associated with traditional drug delivery methods. Investors should note that Gelteq’s current ratio of 0.08 indicates potential liquidity concerns, one of several key insights available through InvestingPro’s comprehensive financial analysis tools.
Healthy Extracts, a developer and marketer of plant-based health supplements, focuses on brain, heart, and gut health. Its clinically tested formulas and exclusive partnerships aim to deliver substantial wellness solutions.
This press release contains forward-looking statements regarding the expected benefits of the partnership, the timing of product distribution, and the potential for operational and financial growth. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially. Investors can track the company’s progress when it reports its next earnings on June 27, 2025.
This news article is based on a press release statement from Gelteq Limited.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.